Literature DB >> 1592343

Hemodynamic and liver function predictors of serum hyaluronan in alcoholic liver disease.

P R Gibson1, J R Fraser, T J Brown, C F Finch, P A Jones, J C Colman, F J Dudley.   

Abstract

To define hepatic predictors of serum hyaluronan in patients with chronic liver disease, 62 patients with alcoholic liver disease were evaluated. In group 1, 30 patients had concurrent assessment of serum hyaluronan, liver function tests, Pugh grade and hemodynamic indices. A second, overlapping group of 42 patients (group 2) also had antipyrine clearance measured but without hemodynamic assessment. All but six patients had elevated serum hyaluronan levels. In both groups, serum hyaluronan levels differed between Pugh grades and, in each group, was significantly greater in Pugh grade C compared with those in Pugh grade A (p less than 0.05, Kruskal-Wallis test). When analyzed by correlation, serum hyaluronan was significantly associated with several indices in group 1, but on multivariate linear regression only three statistically independent predictors of serum hyaluronan were identified: serum albumin (p = 0.008), indocyanine green clearance (p = 0.024) and indocyanine green extraction (p = 0.036). The overall R2 for these correlates was 65%. In the second group, antipyrine clearance was not significantly associated with serum hyaluronan (r = 0.29, p = 0.06), but other associations were similar to the first group. On multivariate analysis, only serum albumin predicted serum hyaluronan (p less than 0.001; R2 = 43%). In conclusion, indices of hepatocyte synthetic function, sinusoidal blood flow and degree of intrahepatic shunting are independent predictors of serum hyaluronan in alcoholic liver disease. These data show the unique nature of serum hyaluronan and suggest its potential application to the assessment of acute hemodynamic changes in patients with liver disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1592343     DOI: 10.1002/hep.1840150614

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  11 in total

1.  Liver impairment in critical illness and sepsis: the dawn of new biomarkers?

Authors:  Martin Kluge; Frank Tacke
Journal:  Ann Transl Med       Date:  2019-12

2.  Early effect of a single intravenous injection of ethanol on hepatic sinusoidal endothelial fenestrae in rabbits.

Authors:  Frank Jacobs; Eddie Wisse; Bart De Geest
Journal:  Comp Hepatol       Date:  2009-07-13

3.  A disturbance of the gastric myoelectric activity in post-operative patients with biliary atresia.

Authors:  Masahiro Ohtaki; Minoru Yagi; Masayuki Kubota; Shinji Homma
Journal:  Pediatr Surg Int       Date:  2004-01-14       Impact factor: 1.827

4.  Serum hyaluronate in patients with acute and fulminant hepatitis.

Authors:  K Suzuki; R Endo; Y Takikawa; I Nakadate; S Sato
Journal:  J Gastroenterol       Date:  1996-04       Impact factor: 7.527

5.  Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage.

Authors:  Masato Yoneda; Hironori Mawatari; Koji Fujita; Kyoko Yonemitsu; Shingo Kato; Hirokazu Takahashi; Hiroyuki Kirikoshi; Masahiko Inamori; Yuichi Nozaki; Yasunobu Abe; Kensuke Kubota; Satoru Saito; Tomoyuki Iwasaki; Yasuo Terauchi; Shinji Togo; Shiro Maeyama; Atsushi Nakajima
Journal:  J Gastroenterol       Date:  2007-05-25       Impact factor: 7.527

6.  Anti-inflammatory and anti-apoptotic roles of endothelial cell STAT3 in alcoholic liver injury.

Authors:  Andrew M Miller; Hua Wang; Ogyi Park; Norio Horiguchi; Fouad Lafdil; Partha Mukhopadhyay; Akira Moh; Xin Yuan Fu; George Kunos; Pal Pacher; Bin Gao
Journal:  Alcohol Clin Exp Res       Date:  2010-01-26       Impact factor: 3.455

7.  Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus.

Authors:  Philippe Halfon; Marc Bourlière; Guillaume Pénaranda; Romaric Deydier; Christophe Renou; Danielle Botta-Fridlund; Albert Tran; Isabelle Portal; Isabelle Allemand; Alessandra Rosenthal-Allieri; Denis Ouzan
Journal:  Comp Hepatol       Date:  2005-07-11

8.  Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B.

Authors:  Ghodrat Montazeri; Arezoo Estakhri; Mehdi Mohamadnejad; Negin Nouri; Farhad Montazeri; Ashraf Mohammadkani; Mohammad Hossain Derakhshan; Farhad Zamani; Shahram Samiee; Reza Malekzadeh
Journal:  BMC Gastroenterol       Date:  2005-10-12       Impact factor: 3.067

Review 9.  Non-invasive assessment of liver fibrosis.

Authors:  Vasilios Papastergiou; Emmanuel Tsochatzis; Andrew K Burroughs
Journal:  Ann Gastroenterol       Date:  2012

Review 10.  Evaluation of liver fibrosis: "Something old, something new…".

Authors:  Zannis Almpanis; Maria Demonakou; Dina Tiniakos
Journal:  Ann Gastroenterol       Date:  2016-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.